Lunch & Poster Session 2 — ASN Events
12:30PM - 2:00PM
Foyer Area


Single-cell analysis results of the patient's blood in the phase I clinical trial of allogeneic iPS cell-derived invariant NKT cell monotherapy (#151)

12:30 PM
Takahiro Aoki

Pooled in vivo CRISPR screen for MAIT cell memory after Live Bacteria Vaccination (#152)

12:30 PM
Gabriel Ascui-Gac

Metabolic profile of human iNKT cells supports antitumor function in nutrient-deprived tumor environments (#153)

12:30 PM
Nikhila S Bharadwaj

MAIT cells possess direct cytotoxic potential against liver cancer, but are rendered dysfunctional within the tumour microenvironment (#154)

12:30 PM
Katrin Böttcher

CD1c Transgenic Mice as a Preclinical Platform for Evaluating CD1c-Restricted T Cell Immunity and Therapeutic Safety (#155)

12:30 PM
Michela Consonni

CAR-iNKT cell adoptive immunotherapy for metastatic colon cancer   (#156)

12:30 PM
Gloria Delfanti

Lactobacillaceae as protective MAIT cell activators in the vagina? (#157)

12:30 PM
Caroline EMK Dricot

Development of nanobodies to isolate and manipulate MAIT cells in humans and mice (#159)

12:30 PM
Nicholas A Gherardin

Characterization of the regulatory landscape of IL-17-producing human MAIT cells (#160)

12:30 PM
Katie Healy

Cord-derived invariant Natural Killer T cells to improve the outcome of hematopoietic stem cell transplantation (#161)

12:30 PM
Jin Im

Competition between KIR3DL3 and TMIGD2 is a checkpoint mechanism for γδ and CD8+ T cells (#162)

12:30 PM
Laura Leaton

Investigating infection-associated T cell antigens presented by MR1 (#163)

12:30 PM
Songyi Li

Perturbation of Invariant Natural Killer T cells by the Clonal Hematopoiesis-related inflammatory environment (#164)

12:30 PM
Francesca Luca

Phenotyping of peripheral MAIT cells from an HIV and Aging cohort using a 35-color spectral flow cytometry panel reveals the phenotypic diversity and specific age-associated enrichment of the CD4+ compartment (#165)

12:30 PM
Christina S McConney

The Unconventional Nature of the Human T Cell Response to Streptococcus pyogenes (#166)

12:30 PM
Christopher Menne

Past the pore of no return: Utilisation of the necroptotic program by MAIT cells (#167)

12:30 PM
Timothy Patton

Metabolic fuel choices control mouse and human MAIT cell functions (#168)

12:30 PM
Tom Riffelmacher

CD1b-restricted cytotoxic T cells recognizing a mycobacterial lipid TMM are conserved across primates (#169)

12:30 PM
Yuki Sakai

MAIT cell activation in HIV-induced neuroinflammation (#170)

12:30 PM
Emily M. Slaby

Mucosal-Associated Invariant T cells: Potential Adoptive Cellular Immunotherapy (#171)

12:30 PM
Ebony Smith

Blockade of AhR signaling augments the efficacy of NKT cell-based immunotherapy (#172)

12:30 PM
Mariko Takami

Optimized Syngeneic Neuroblastoma Models to Advance Cell Therapies (#174)

12:30 PM
Ying Wang

Generation of allogeneic CAR-NKT cells from HSPCs using a clinically guided culture method for cancer immunotherapy (#175)

12:30 PM
Lili Yang

Spatially resolved single-cell profiling reveals MAIT cell roles in sterile lung injury (#176)

12:30 PM
Xiawei Zhang